Your browser doesn't support javascript.
loading
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal data.
Ravichandran, Sriram; Cohen, Oliver C; Law, Steven; Sachchithanantham, Sajitha; Mahmood, Shameem; Foard, Darren; Fontana, Marianna; Martinez-Naharro, Ana; Whelan, Carol; Gillmore, Julian D; Lachmann, Helen J; Hawkins, Philip N; Wechalekar, Ashutosh D.
Afiliação
  • Ravichandran S; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Cohen OC; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Law S; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Sachchithanantham S; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Mahmood S; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Foard D; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Fontana M; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Martinez-Naharro A; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Whelan C; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Gillmore JD; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Lachmann HJ; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Hawkins PN; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Wechalekar AD; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
Br J Haematol ; 194(3): 587-597, 2021 08.
Article em En | MEDLINE | ID: mdl-34189728
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bortezomib / Amiloidose de Cadeia Leve de Imunoglobulina / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bortezomib / Amiloidose de Cadeia Leve de Imunoglobulina / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article